Interactions between COPD and outcomes after percutaneous coronary intervention

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00209775%3A_____%2F10%3A%230000136" target="_blank" >RIV/00209775:_____/10:#0000136 - isvavai.cz</a>

Výsledek na webu

—

DOI - Digital Object Identifier

—

Jazyk výsledku

angličtina

Název v původním jazyce

Interactions between COPD and outcomes after percutaneous coronary intervention

Popis výsledku v původním jazyce

COPD is common in patients undergoing percutaneous coronary intervention (PCI), but its association with outcomes following PCI has received only limited study. We conducted a retrospective cross-sectional analysis of prospectively acquired data in 14,346 patients. The COPD group included 2,001 patients (72% men) aged 70 +- 10 years, and the non-COPD group included 12,345 patients (70% men) aged 66 +- 12 years. In the follow-up period after PCI (median, 4.1 years), the patients with COPD experienced a significantly higher incidence of all-cause mortality (P < .0001), cardiac mortality (P < .0001), and myocardial infarction (MI) (P < .0001) than the patients without COPD. Additionally, severity of COPD was associated with increased mortality after PCI (P < .0001). Screening for COPD in patients undergoing PCI could contribute importantly to risk stratification, identifying patients needing closer follow-up and optimizing targeted therapeutic interventions.

Název v anglickém jazyce

Interactions between COPD and outcomes after percutaneous coronary intervention

Popis výsledku anglicky

COPD is common in patients undergoing percutaneous coronary intervention (PCI), but its association with outcomes following PCI has received only limited study. We conducted a retrospective cross-sectional analysis of prospectively acquired data in 14,346 patients. The COPD group included 2,001 patients (72% men) aged 70 +- 10 years, and the non-COPD group included 12,345 patients (70% men) aged 66 +- 12 years. In the follow-up period after PCI (median, 4.1 years), the patients with COPD experienced a significantly higher incidence of all-cause mortality (P < .0001), cardiac mortality (P < .0001), and myocardial infarction (MI) (P < .0001) than the patients without COPD. Additionally, severity of COPD was associated with increased mortality after PCI (P < .0001). Screening for COPD in patients undergoing PCI could contribute importantly to risk stratification, identifying patients needing closer follow-up and optimizing targeted therapeutic interventions.

Druh

J_x - Nezařazeno - Článek v odborném periodiku (Jimp, Jsc a Jost)

CEP obor

FA - Kardiovaskulární nemoci včetně kardiochirurgie

OECD FORD obor

—

Projekt

—

Návaznosti

V - Vyzkumna aktivita podporovana z jinych verejnych zdroju

Rok uplatnění

2010

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Název periodika

Chest

ISSN

0012-3692

e-ISSN

—

Svazek periodika

138

Číslo periodika v rámci svazku

3

Stát vydavatele periodika

US - Spojené státy americké

Počet stran výsledku

7

Strana od-do

—

Kód UT WoS článku

000282561500026

EID výsledku v databázi Scopus

—